var title_f7_53_8016="Bleeding tumor b";
var content_f7_53_8016=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80352&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angiogram of the left cervicovaginal artery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 497px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Angiogram of the left cervicovaginal artery shows occlusion of the artery. Previously seen opacification of neovascularity is no longer present. Note that there is residual tumor staining from contrast injections during the procedure. There was significant improvement in her vaginal bleeding after the embolization procedure.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8016=[""].join("\n");
var outline_f7_53_8016=null;
var title_f7_53_8017="Complete UCL tear";
var content_f7_53_8017=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82259&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ulnar collateral ligament: Complete tear",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 291px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Abduction stress placed upon the ulnar collateral ligament in this photograph reveals loss of a distinct endpoint and grossly abnormal motion, which are consistent with a complete ligament tear.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8017=[""].join("\n");
var outline_f7_53_8017=null;
var title_f7_53_8018="Mini-case session #4: Metabolic acidosis";
var content_f7_53_8018=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Mini-case session #4: Metabolic acidosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Burton D Rose, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8018/contributors\">",
"     Theodore W Post, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/53/8018/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   May 28, 1995.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     CASE 1",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 51 year-old man passes out while waiting in the Emergency department. He is noted to have no pulse and cardiopulmonary resuscitation is begun. Initial laboratory data show:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.30",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Arterial PCO2 &nbsp;= &nbsp;30 mmHg",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;140",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;4.1",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;100",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp;= &nbsp;15",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What is the acid-base disorder? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;Calculate the anion gap? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What is the most likely diagnosis?",
"   </p>",
"   <p>",
"    A Swan-Ganz catheter has been inserted and mixed venous blood gases are obtained at the same time as the above arterial sample:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;pH &nbsp;= &nbsp;7.00",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;PCO2 &nbsp;= &nbsp;64 mmHg",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Bicarbonate &nbsp;= &nbsp;16",
"    <span class=\"nowrap\">",
"     meq/L",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;How do you account for the difference between the arterial and mixed venous results? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=see_link\">",
"     \"Arterial blood gases\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;Which is likely to be a more accurate reflection of acid-base status at the tissue level?",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CASE 2",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 23 year-old man with no prior history complains of polyuria, polydipsia, and polyphagia for 2 weeks. He also notes some shortness of breath. The physical examination reveals a blood pressure of",
"    <span class=\"nowrap\">",
"     120/80",
"    </span>",
"    supine,",
"    <span class=\"nowrap\">",
"     90/60",
"    </span>",
"    standing, increased respiratory rate, and decreased skin turgor. The initial laboratory data reveal:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;140",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;6.1",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;100",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp;= &nbsp;5",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma glucose &nbsp;= &nbsp;840",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;BUN &nbsp;= &nbsp;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma creatinine &nbsp;= &nbsp;4.2",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Serum ketones &nbsp;= &nbsp;4+ at 1:4 dilution",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine ketones &nbsp;= &nbsp;4+",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine glucose &nbsp;= &nbsp;4+",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine sodium &nbsp;= &nbsp;53",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine potassium &nbsp;= &nbsp;32",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Urine osmolality &nbsp;= &nbsp;420",
"    <span class=\"nowrap\">",
"     mosmol/kg",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.00",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Arterial PCO2 &nbsp;= &nbsp;20 mmHg",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What is the mechanism by which ketoacid formation is increased in diabetic ketoacidosis?",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;The osmotic diuresis induced by unreabsorbed glucose (since the filtered load exceeds reabsorptive capacity), leads to urinary losses of glucose, sodium, and water. In addition, ketoacid anions are also lost because of the high filtered load. What is the physiologic significance of these losses? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=see_link\">",
"     \"Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What effect will the loss of urine with the above composition have on the plasma sodium concentration? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36857?source=see_link&amp;anchor=H190652569#H190652569\">",
"     \"Etiology and evaluation of hypernatremia\", section on 'Determinants of the serum sodium concentration'",
"    </a>",
"    )",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     CASE 3",
"    </span>",
"    &nbsp;&mdash;&nbsp;A 1 year-old child was seen by his pediatrician for a routine evaluation and was found to weigh 10 kg. Two days later, he is seen in the Emergency Department for diarrhea and dehydration. At this time, the physical examination reveals a pulse of 140, respiratory rate",
"    <span class=\"nowrap\">",
"     32/min,",
"    </span>",
"    blood pressure",
"    <span class=\"nowrap\">",
"     90/&ndash;,",
"    </span>",
"    and weight 8.9 kg. He appears moderately dehydrated with dry mucous membranes and no tears when he cried. There are no other significant abnormalities. Laboratory data on admission reveal:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp;Plasma sodium &nbsp;= &nbsp;138",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma potassium &nbsp;= &nbsp;4.0",
"    <span class=\"nowrap\">",
"     meq/l",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma chloride &nbsp;= &nbsp;104",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma bicarbonate &nbsp; = &nbsp;11",
"    <span class=\"nowrap\">",
"     meq/L",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;BUN &nbsp;= &nbsp;32",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Plasma creatinine &nbsp;= &nbsp;0.6",
"    <span class=\"nowrap\">",
"     mg/dL",
"     <br/>",
"    </span>",
"    &nbsp; &nbsp; &nbsp;Arterial pH &nbsp;= &nbsp;7.24",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Arterial PCO2 &nbsp;= &nbsp;24 mmHg",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine pH &nbsp;= &nbsp;5.0",
"    <br/>",
"    &nbsp; &nbsp; &nbsp;Urine specific gravity &nbsp;= &nbsp;1.031",
"   </p>",
"   <p>",
"    &nbsp;A. &nbsp;What is the acid-base disorder? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=see_link\">",
"     \"Simple and mixed acid-base disorders\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;B. &nbsp;What is the anion gap and what does it tell you about the etiology of the acid-base disorder? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31432?source=see_link\">",
"     \"Approach to the adult with metabolic acidosis\"",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    &nbsp;C. &nbsp;What is the approximate fluid deficit?",
"   </p>",
"   <p>",
"    &nbsp;D. &nbsp;What is the approximate sodium plus potassium deficit?",
"   </p>",
"   <p>",
"    &nbsp;E. &nbsp;If all of the excess unmeasured anions are metabolized to bicarbonate, will this raise the plasma bicarbonate concentration to normal? (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21526?source=see_link\">",
"     \"The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis\"",
"    </a>",
"    ).",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7247 Version 5.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-210.101.131.232-8A237B75EA-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8018=[""].join("\n");
var outline_f7_53_8018=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      CASE 1",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CASE 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      CASE 3",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/44/31432?source=related_link\">",
"      Approach to the adult with metabolic acidosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/33/15894?source=related_link\">",
"      Arterial blood gases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/55/4986?source=related_link\">",
"      Clinical features and diagnosis of diabetic ketoacidosis and hyperosmolar hyperglycemic state in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/63/36857?source=related_link\">",
"      Etiology and evaluation of hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/41/27288?source=related_link\">",
"      Simple and mixed acid-base disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/1/21526?source=related_link\">",
"      The &Delta;anion gap/&Delta;HCO3 ratio in patients with a high anion gap metabolic acidosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_53_8019="Cervical cancer screening";
var content_f7_53_8019=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Cervical cancer screening (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/53/8019/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8019/contributors\" id=\"au1239\">",
"       Brenda E Sirovich, MD, MS",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/53/8019/contributors\">",
"       Section Editors",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8019/contributors\" id=\"se4183\">",
"       Suzanne W Fletcher, MD",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8019/contributors\" id=\"se7382\">",
"       Barbara Goff, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"UTD.htm?7/53/8019/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8019/contributors\" id=\"de162\">",
"       H Nancy Sokol, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"UTD.htm?7/53/8019?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      CERVICAL CANCER SCREENING OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     The Papanicolaou smear (Pap test) is a test used to screen women for cervical precancer or cancer. Testing for human papillomavirus (HPV) is another type of test for cervical cancer that can be used in women over age 30 in conjunction with the Pap test.",
"    </p>",
"    <p>",
"     Pap tests can find cervical cancer and precancer in the early stages when it can be treated, and thus may reduce the number of deaths from cervical cancer. This article reviews tests used to screen for cervical cancer and a description of both normal and abnormal Pap test results.",
"    </p>",
"    <p>",
"     The evaluation and treatment of abnormal Pap tests are discussed separately. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"      \"Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"      \"Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)\"",
"     </a>",
"     and",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14227?source=see_link\">",
"      \"Patient information: Treatment of precancerous cells of the cervix (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      CERVICAL CANCER RISK FACTORS",
"     </span>",
"    </p>",
"    <p>",
"     The most important risk factor for cervical cancer is infection with the human papillomavirus (HPV). There are over 100 different types of HPV, however, most types of HPV do not cause cancer. At least 80 percent of women are exposed to the HPV virus during their lifetime. Most of the time, the body's immune system gets rid of the virus before it does harm.",
"    </p>",
"    <p>",
"     Researchers have labeled the HPV types as being high or low risk for causing cervical cancer.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Low risk types &mdash; HPV types 6 and 11 can cause genital warts and are low-risk types because they rarely cause cervical cancer. (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=see_link\">",
"        \"Patient information: Genital warts in women (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       High risk types &mdash; HPV types 16 and 18 are considered high-risk types because they may cause cervical cancer in some women.",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     HPV is spread by direct skin-to-skin contact, including sexual intercourse, oral sex, anal sex, or any other contact involving the genital area (eg, hand to genital contact). It is not possible to become infected with HPV by touching an object, such as a toilet seat. In 2006, a vaccine became available in the United States to help prevent infection with certain types of HPV. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=see_link\">",
"      \"Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Most people who are infected with HPV have no signs or symptoms. Most HPV infections are temporary and resolve within two years. When the virus persists (in 10 to 20 percent of cases), there is a chance of developing cervical precancer or cancer. However, it usually takes many years for HPV infection to cause cervical cancer.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      CERVICAL CANCER SCREENING TESTS",
"     </span>",
"    </p>",
"    <p>",
"     There are several ways to screen for cervical cancer. The traditional screening test is called a Pap test.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Pap smear",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Pap test is a method of examining cells from the cervix (",
"     <a class=\"graphic graphic_picture graphicRef77157 \" href=\"UTD.htm?42/63/44019\">",
"      picture 1",
"     </a>",
"     ). The cervix is located at the lower end of the uterus (",
"     <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"      figure 1",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     To perform a Pap test, a doctor or other health care provider will perform a pelvic exam and use a small brush or spatula to collect cells from the cervix. The cells are smeared on a glass slide (called a traditional Pap smear) or added to a preservative fluid (called liquid-based, thin layer testing).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      HPV testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;An HPV test can be done along with a Pap test or as a separate test. Like a Pap test, the HPV test is done during a pelvic exam, using a small brush to collect a sample from the cervix. Women who are under age 30 are not usually tested for HPV because many women in this age group have temporary infections, which will go away without treatment.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11175390\">",
"     <span class=\"h1\">",
"      WHO SHOULD HAVE HPV TESTING?",
"     </span>",
"    </p>",
"    <p>",
"     If you are 30 years or older, your doctor or nurse may recommend HPV testing in addition to a Pap test. If your HPV test and Pap test are negative, repeat testing is not usually needed for five years. HPV testing may also be done if the results of your Pap test results are unclear.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      WHO SHOULD HAVE A PAP SMEAR?",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h2\">",
"      Younger women",
"     </span>",
"     &nbsp;&mdash;&nbsp;In the United States, the first Pap test is recommended at age 21; some other countries suggest that screening begin at age 25. Cervical cancer is very rare in younger women.",
"    </p>",
"    <p>",
"     In the past, experts recommended that every woman have a Pap test every year. This has changed, and Pap testing is suggested every three years for most women over age 21. More frequent testing may be needed if test results are not normal, or for women with HIV disease or other specific immune system conditions.",
"    </p>",
"    <p>",
"     Even if you have had a vaccine for human papillomavirus, you will still need cervical cancer screening. (See",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=see_link\">",
"      \"Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Older women",
"     </span>",
"     &nbsp;&mdash;&nbsp;Most experts feel that women who are 65 years or older can stop having Pap tests if:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       You have had Pap tests on a regular basis in the past",
"      </li>",
"      <li>",
"       You have had at least three normal Pap tests (or two tests with combination Pap and HPV test) in the past 10 years, with the most recent in the past five years",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      After hysterectomy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women who have had a total hysterectomy (your uterus and cervix were removed) do not need a Pap test, unless:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       The hysterectomy did not remove your cervix (eg, if the hysterectomy was \"subtotal\")",
"      </li>",
"      <li>",
"       Your hysterectomy was done because of cervical cancer or precancer",
"      </li>",
"      <li>",
"       You were exposed to diethylstilbestrol (DES) during your mother's pregnancy",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      PREPARING FOR YOUR PAP SMEAR",
"     </span>",
"    </p>",
"    <p>",
"     For two days before your Pap test, do not put anything in your vagina (eg, spermicide, creams). A Pap test can be done at any time during your menstrual cycle.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H11\">",
"     <span class=\"h1\">",
"      PAP SMEAR RESULTS",
"     </span>",
"    </p>",
"    <p>",
"     The results from your Pap test will be available a few weeks after your visit. Pap test results may be reported as:",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h2\">",
"      Negative",
"     </span>",
"     &nbsp;&mdash;&nbsp;Pap tests that have no abnormal, precancerous, or cancerous cells are labeled as \"Negative for intraepithelial lesion or malignancy.&rdquo;",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Abnormal results",
"     </span>",
"     &nbsp;&mdash;&nbsp;Cervical cells may appear abnormal for a variety of reasons. For example, you may have a cervical infection, or you may have a precancerous area or even cervical cancer.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Follow-up testing",
"     </span>",
"     &nbsp;&mdash;&nbsp;If your Pap test is abnormal, or if your Pap test is normal but your HPV test is abnormal (positive), you may need follow-up testing; the best strategy depends on several individual factors.",
"    </p>",
"    <p>",
"     Follow-up for abnormal Pap tests is discussed separately.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"        \"Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"        \"Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14227?source=see_link\">",
"        \"Patient information: Treatment of precancerous cells of the cervix (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"      <li>",
"       (See",
"       <a class=\"medical medical_patient\" href=\"UTD.htm?6/48/6914?source=see_link\">",
"        \"Patient information: Colposcopy (Beyond the Basics)\"",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H15\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3498796398\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5508222\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28163?source=see_link\">",
"      Patient information: Cervical cancer (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?9/63/10227?source=see_link\">",
"      Patient information: Cancer screening (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?5/22/5475?source=see_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/8/15491?source=see_link\">",
"      Patient information: Pap tests (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5508273\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/29/2515?source=see_link\">",
"      Patient information: Management of atypical squamous cells (ASC-US and ASC-H) and low grade cervical squamous intraepithelial lesions (LSIL) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?16/44/17092?source=see_link\">",
"      Patient information: Management of high grade cervical squamous intraepithelial lesions (HSIL) and glandular abnormalities (AGC) (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/57/14227?source=see_link\">",
"      Patient information: Treatment of precancerous cells of the cervix (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=see_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=see_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?6/48/6914?source=see_link\">",
"      Patient information: Colposcopy (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H16\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=see_link\">",
"      Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9624?source=see_link\">",
"      Cervical cytology: Evaluation of atypical and malignant glandular cells",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/54/28517?source=see_link\">",
"      Cervical cytology: Evaluation of high grade squamous intraepithelial lesions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/60/6086?source=see_link\">",
"      Cervical cytology: Evaluation of low grade squamous intraepithelial lesions",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/4/37962?source=see_link\">",
"      Overview of preventive medicine in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/16/38154?source=see_link\">",
"      Screening for cervical cancer: Rationale and recommendations",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/4/36934?source=see_link\">",
"      Screening for cervical cancer in HIV infected women",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Society for Colposcopy and Cervical Pathology",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.asccp.org/\">",
"      www.asccp.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Cancer Society",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cancer.org/\">",
"      www.cancer.org",
"     </a>",
"     , search for HPV)",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National HPV and Cervical Cancer Public Education Campaign",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;Telephone: 1-866-280-6605",
"     <br/>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cervicalcancercampaign.org/\">",
"      www.cervicalcancercampaign.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Center for Disease Control and Prevention",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.cdc.gov/\">",
"      www.cdc.gov/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Social Health Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.ashastd.org/\">",
"      file://www.ashastd.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"UTD.htm?7/53/8019/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 17, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"UTD.htm?7/53/8019?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8019/abstract/1\">",
"      Koutsky LA, Ault KA, Wheeler CM, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347:1645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8019/abstract/2\">",
"      Villa LL, Costa RL, Petta CA, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8019/abstract/3\">",
"      International Collaboration of Epidemiological Studies of Cervical Cancer, Appleby P, Beral V, et al. Carcinoma of the cervix and tobacco smoking: collaborative reanalysis of individual data on 13,541 women with carcinoma of the cervix and 23,017 women without carcinoma of the cervix from 23 epidemiological studies. Int J Cancer 2006; 118:1481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8019/abstract/4\">",
"      Wright TC Jr, Cox JT, Massad LS, et al. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287:2120.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8019/abstract/5\">",
"      American College of Obstetricians and Gynecologists. ACOG Practice Bulletin number 66, September 2005. Management of abnormal cervical cytology and histology. Obstet Gynecol 2005; 106:645.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f7_53_8019=[""].join("\n");
var outline_f7_53_8019=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           CERVICAL CANCER SCREENING OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           CERVICAL CANCER RISK FACTORS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           CERVICAL CANCER SCREENING TESTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11175390\">",
"           WHO SHOULD HAVE HPV TESTING?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           WHO SHOULD HAVE A PAP SMEAR?",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           PREPARING FOR YOUR PAP SMEAR",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H11\">",
"           PAP SMEAR RESULTS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H15\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\" title=\"figure 1\">",
"           Female anatomy PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          PICTURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/63/44019\" title=\"picture 1\">",
"           Normal cervix PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f7_53_8020="Soft tissue filler injection techniques";
var content_f7_53_8020=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F51440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F51440&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 547px\">",
"   <div class=\"ttl\">",
"    Soft tissue filler injection techniques",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 527px; height: 651px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8020=[""].join("\n");
var outline_f7_53_8020=null;
var title_f7_53_8021="Balsalazide: Drug information";
var content_f7_53_8021=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Balsalazide: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?30/55/31604?source=see_link\">",
"    see \"Balsalazide: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/14/37092?source=see_link\">",
"    see \"Balsalazide: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F139019\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Colazal&reg;;",
"     </li>",
"     <li>",
"      Giazo&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F139034\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      5-Aminosalicylic Acid Derivative;",
"     </li>",
"     <li>",
"      Anti-inflammatory Agent",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F139021\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Ulcerative colitis:",
"     </b>",
"     Oral:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Capsule:",
"     </i>",
"     2.25 g (three 750 mg capsules) 3 times daily for up to 8-12 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Tablet (Giazo&trade;):",
"     </i>",
"     Males: 3.3 g (three 1.1 g tablets) twice daily for up to 8 weeks",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F4005150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/14/37092?source=see_link\">",
"      see \"Balsalazide: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Ulcerative colitis:",
"     </b>",
"     Oral: Capsule: Children 5-17 years: 750 mg 3 times daily for up to 8 weeks",
"     <b>",
"      or",
"     </b>",
"     2.25 g (three 750 mg capsules) 3 times daily for up to 8 weeks",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F139022\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F139023\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling. Renal toxicity has been observed with other 5-aminosalicylic acid products; use with caution.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F2558398\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F139002\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral, as disodium: 750 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Colazal&reg;: 750 mg [contains sodium ~86 mg/capsule]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral, as disodium:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Giazo&trade;: 1.1 g [contains sodium ~126 mg/tablet]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F138989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Capsule",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F3347863\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Capsule: Should be swallowed whole or may be opened and sprinkled on applesauce. Applesauce mixture may be chewed; swallow immediately, do not store mixture for later use. When sprinkled on food, may cause staining of teeth or tongue.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tablet: Administer with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F139003\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of mildly- to moderately-active ulcerative colitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Giazo&trade;: Only approved in males &ge;18 years; effectiveness in females was not demonstrated",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F139041\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Colazal&reg; may be confused with Clozaril&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F139032\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (children 15%; adults 8%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Abdominal pain (children 12% to 13%; adults &le;6%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Insomnia (adults 2%), fatigue (children 4%; adults &le;2%), fever (children 6%; adults 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Dysmenorrhea (children 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Vomiting (children 10%; adults &le;4%), diarrhea (children 9%; adults &le;5%), ulcerative colitis exacerbation (children 6%; adults 1%), nausea (children 4%; adults 5%), hematochezia (children 4%), stomatitis (children 3%), anorexia (adults 2%), dyspepsia (adults 2%), flatulence (adults &le;2%), cramps (adults 1%), constipation (adults &le;1%), xerostomia (adults &le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection (adults 1% to 4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hematologic: Anemia (4%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia (adults &le;4%), musculoskeletal pain (adults 2%), myalgia (adults &le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Respiratory infection (adults &le;4%), cough (children 3%; adults 2%), pharyngitis (children 6%; adults 2%), pharyngolaryngeal pain (children 3%; adults 4%), rhinitis (adults 2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Flu-like syndrome (children 4%; adults 1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Alopecia, alveolitis, AST increased, back pain, blood pressure increased, cholestatic jaundice, cirrhosis, defecation urgency, dizziness, dyspnea, edema, erythema nodosum, facial edema, fever, gastroenteritis, gastroesophageal reflux, hard stool, heart rate increased, hepatocellular damage, hepatotoxicity, hyperbilirubinemia, hypersensitivity, interstitial nephritis, jaundice, Kawasaki-like syndrome, lethargy, liver failure, liver necrosis, liver function tests increased, malaise, myocarditis, pain, pancreatitis, pericarditis, pleural effusion, pneumonia (with and without eosinophilia), pruritus, rash, renal failure, vasculitis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F139006\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to balsalazide or its metabolites, salicylates, or any component of the formulation",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F138993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Colitis: Symptomatic worsening of ulcerative colitis may occur following initiation of treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intolerance syndrome: May cause an acute intolerance syndrome (cramping, acute abdominal pain, bloody diarrhea; sometimes fever, headache, rash); discontinue if this occurs.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Staining: May cause staining of teeth or tongue if capsule is opened and sprinkled on food.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hepatic impairment: Use caution in patients with hepatic dysfunction; hepatic failure has been observed with other mesalamine (5-aminosalicylic acid) products.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pyloric stenosis: Use with caution in patients with pyloric stenosis; prolonged gastric retention may occur and delay release of drug in the colon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; renal toxicity has been observed with other mesalamine (5-aminosalicylic acid) products.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298812\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F138997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiac Glycosides: 5-ASA Derivatives may decrease the serum concentration of Cardiac Glycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin: 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin. Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Heparin (Low Molecular Weight): 5-ASA Derivatives may enhance the adverse/toxic effect of Heparin (Low Molecular Weight). Specifically, the risk for bleeding/bruising may be increased.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Thiopurine Analogs: 5-ASA Derivatives may decrease the metabolism of Thiopurine Analogs.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Varicella Virus-Containing Vaccines: 5-ASA Derivatives may enhance the adverse/toxic effect of Varicella Virus-Containing Vaccines. The primary concern is the potential development of Reye's Syndrome, a condition that has been associated with the use of salicylates in children with varicella infections.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F138999\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F139008\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic effects were not observed in animal reproduction studies. Mesalamine (5-aminosalicylic acid) is the active metabolite of balsalazide; mesalamine is known to cross the placenta.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F139024\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F13316162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Mesalamine, 5-aminosalicylic acid, is the active metabolite of balsalazide. Low levels of mesalamine enter breast milk; a case of bloody diarrhea in a breast-fed infant has been reported.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F4005612\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Some products may contain sodium. Take tablets with or without food.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F139007\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Balsalazide Disodium Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (280): $447.77",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Colazal Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     750 mg (280): $477.67",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Giazo Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.1 g (180): $900.00",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F4005151\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Improvement or worsening of symptoms; renal function (prior to initiation, then periodically); liver function tests",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F5539822\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Ao Rui Xin (CL);",
"     </li>",
"     <li>",
"      Balzide (IT);",
"     </li>",
"     <li>",
"      Basazyde (TW);",
"     </li>",
"     <li>",
"      Benoquin (AR);",
"     </li>",
"     <li>",
"      Colazal (KP);",
"     </li>",
"     <li>",
"      Colazid (NO, SE);",
"     </li>",
"     <li>",
"      Colazide (AT, AU, GB, NZ);",
"     </li>",
"     <li>",
"      Colorex (IN);",
"     </li>",
"     <li>",
"      Garian (UY);",
"     </li>",
"     <li>",
"      Intazide (IN);",
"     </li>",
"     <li>",
"      Premid (DK);",
"     </li>",
"     <li>",
"      Sai Lai De (CL)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F138992\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Balsalazide is a prodrug, converted by bacterial azoreduction to 5-aminosalicylic acid (mesalamine, active), 4-aminobenzoyl-&beta;-alanine (inert), and their metabolites. 5-aminosalicylic acid may decrease inflammation by blocking the production of arachidonic acid metabolites topically in the colon mucosa.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F139005\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Delayed; may require several days to weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Very low and variable",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Balsalazide: &ge;99%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Azoreduced in the colon to 5-aminosalicylic acid (active), 4-aminobenzoyl-&beta;-alanine (inert), and N-acetylated metabolites",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Primary effect is topical (colonic mucosa); therapeutic effect appears not to be influenced by the systemic half-life of balsalazide (1.9 hours) or its metabolites (5-ASA [9.5 hours], N-Ac-5-ASA [10.4 hours])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak: Balsalazide: Capsule: 1-2 hours; Tablet: 0.5 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (65% as 5-aminosalicylic acid, 4-aminobenzoyl-&beta;-alanine, and N-acetylated metabolites); urine (&lt;16% as N-acetylated metabolites); Parent drug: Urine or feces (&lt;1%)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Adhiyaman V, Vaishnavi A, and Froese A, &ldquo;Drug Points: Hypersensitivity Reaction to Balsalazide,&rdquo;",
"      <i>",
"       BMJ",
"      </i>",
"      , 2001, 323(7311):489.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/11532843/pubmed\" id=\"11532843\" target=\"_blank\">",
"        11532843",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Connell W and Miller A, &ldquo;Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy,&rdquo;",
"      <i>",
"       Drug Safety",
"      </i>",
"      , 1999, 21(4):311-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/10514022/pubmed\" id=\"10514022\" target=\"_blank\">",
"        10514022",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Diav-Citrin O, Park YH, Veerasuntharam G, et al, &ldquo;The Safety of Mesalamine in Human Pregnancy: A Prospective Controlled Cohort Study,&rdquo;",
"      <i>",
"       Gastroenterology",
"      </i>",
"      , 1998, 114(1):23-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/9428214/pubmed\" id=\"9428214\" target=\"_blank\">",
"        9428214",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dubinsky M, Abraham B, and Mahadevan U, &ldquo;Management of the Pregnant IBD Patient,&rdquo;",
"      <i>",
"       Inflamm Bowel Dis",
"      </i>",
"      , 2008, 14(12):1736-50.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/18626967/pubmed\" id=\"18626967\" target=\"_blank\">",
"        18626967",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kornbluth A and Sachar DB, &ldquo;Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee,&rdquo;",
"      <i>",
"       Am J Gastroenterol",
"      </i>",
"      , 2010, 105(3):501-23.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/20068560/pubmed\" id=\"20068560\" target=\"_blank\">",
"        20068560",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lennard L, &ldquo;Clinical Implications of Thiopurine Methyltransferase - Optimization of Drug Dosage and Potential Drug Interactions,&rdquo;",
"      <i>",
"       Ther Drug Monit",
"      </i>",
"      , 1998, 20(5):527-31.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/9780130/pubmed\" id=\"9780130\" target=\"_blank\">",
"        9780130",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Robertson E, Austin D, Jamieson N, et al, &ldquo;Balsalazide-Induced Myocarditis,&rdquo;",
"      <i>",
"       Int J Cardiol",
"      </i>",
"      , 2008, 130(3):e121-2.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8021/abstract-text/17889383/pubmed\" id=\"17889383\" target=\"_blank\">",
"        17889383",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8713 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-180.241.123.62-BF10BB01C4-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8021=[""].join("\n");
var outline_f7_53_8021=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139019\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139034\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139021\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4005150\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139022\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139023\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2558398\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139002\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138989\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3347863\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139003\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139041\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139032\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139006\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138993\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298812\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138997\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138999\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139008\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139024\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13316162\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4005612\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139007\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4005151\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5539822\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F138992\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F139005\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8713\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8713|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?30/55/31604?source=related_link\">",
"      Balsalazide: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/14/37092?source=related_link\">",
"      Balsalazide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_53_8022="Azelastine (nasal): Drug information";
var content_f7_53_8022=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Azelastine (nasal): Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?11/54/12132?source=see_link\">",
"    see \"Azelastine (nasal): Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/20/5445?source=see_link\">",
"    see \"Azelastine (nasal): Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7976934\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Astelin&reg;;",
"     </li>",
"     <li>",
"      Astepro&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F7976935\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Astelin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F7976939\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Histamine H;",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist",
"     </li>",
"     <li>",
"      Histamine H",
"      <sub>",
"       1",
"      </sub>",
"      Antagonist, Second Generation",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F7977043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seasonal allergic rhinitis",
"     </b>",
"     (Astelin&reg;, Astepro&reg;): Intranasal: 1-2 sprays each nostril twice daily.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Vasomotor rhinitis",
"     </b>",
"     (Astelin&reg;): Intranasal: 2 sprays each nostril twice daily.",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F7977042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/20/5445?source=see_link\">",
"      see \"Azelastine (nasal): Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Seasonal allergic rhinitis:",
"     </b>",
"     Intranasal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Astelin&reg;: Children 5-11 years: 1 spray each nostril twice daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Astelin&reg;, Astepro&reg;: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Vasomotor rhinitis",
"     </b>",
"     (Astelin&reg;): Intranasal: Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F7977044\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F15794418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment provided in manufacturer&rsquo;s labeling.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F15794419\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No dosage adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F7977055\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, intranasal, as hydrochloride [spray]: 0.1% [137 mcg/spray] (30 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Astelin&reg;: 0.1% [137 mcg/spray] (30 mL) [contains benzalkonium chloride; 200 metered sprays]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Astepro&reg;: 0.15% [205.5 mcg/spray] (30 mL) [contains benzalkonium chloride; 200 metered sprays]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F7976937\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F7977046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Before initial use of the nasal spray, the delivery system should be primed with 4 sprays (Astelin&reg;), with 6 sprays (Astepro&reg;), or until a fine mist appears. If 3 or more days have elapsed since last use, the delivery system should be reprimed with 2 sprays or until a fine mist appears. Blow nose to clear nostrils. Keep head tilted downward when spraying. Insert applicator into nostril, keeping bottle upright, and close off the other nostril. Breathe in through nose. While inhaling, press pump to release spray. Alternate sprays between nostrils. After each use, wipe the spray tip with a clean tissue or cloth. Avoid spraying in eyes or mouth.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F7976942\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     Treatment of the symptoms of seasonal allergic rhinitis such as rhinorrhea, sneezing, and nasal pruritus; treatment of the symptoms of vasomotor rhinitis",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F7976926\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Astelin&reg; may be confused with Astepro&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F7976971\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Adverse reactions may be dose-, indication-, or product-dependent:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &gt;10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Headache (Astelin&reg; 8% to 15%; Astepro&reg; 1% to 3%), somnolence (&lt;1% to 12%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Bitter taste (Astelin&reg; 8% to 20%; Astepro&reg; 6% to 7%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Cold symptoms/rhinitis (2% to 17%), cough (11%)",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;text-align:justify;\">",
"     2% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Dysesthesia (8%), dizziness (2%), fatigue (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Nausea (3%), weight gain (2%), xerostomia (3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Myalgia (&le;2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Conjunctivitis (&lt;2% to 5%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Asthma (5%), nasal burning (4%), pharyngitis (4%), paroxysmal sneezing (3%), sinusitis (3%), epistaxis (2% to 3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;2%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Cardiovascular: Flushing, hypertension, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Central nervous system: Abnormal thinking, anxiety, depersonalization, depression, drowsiness, fever, hypoesthesia, malaise, nervousness, sleep disorder, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Dermatologic: Contact dermatitis, eczema, furunculosis, hair and follicle infection, skin laceration",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, breast pain",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, aphthous stomatitis, appetite increased, constipation, diarrhea, gastroenteritis, glossitis, loss of taste, ulcerative stomatitis, toothache, vomiting",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Genitourinary: Albuminuria, hematuria, polyuria",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Hepatic: ALT increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Back pain, extremity pain, hyperkinesia, rheumatoid arthritis, temporomandibular dislocation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Ocular: Eye pain, watery eyes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Respiratory: Bronchitis, bronchospasm, laryngitis, nasal congestion, nocturnal dyspnea, pharyngolaryngeal pain, postnasal drip, sinus hypersecretion, throat burning",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Miscellaneous: Allergic reactions, herpes simplex infection, viral infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     &lt;1% (Limited to important or life-threatening): Anaphylactoid reaction, atrial fibrillation, blurred vision, chest pain, confusion, facial edema, involuntary muscle contractions, loss of smell, paresthesia, parosmia, rash, tolerance, transaminases increased, urinary retention, xerophthalmia",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F7976967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to azelastine or any component of the formulation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Astepro&reg;: There are no contraindications in the manufacturers&rsquo; product labeling.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F7976968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; May cause drowsiness in some patients; instruct patient to use caution when driving or operating machinery. Effects may be additive with CNS depressants and/or ethanol.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F7976976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Substrate",
"     </b>",
"     of CYP1A2 (minor), CYP2C19 (minor), CYP2D6 (minor), CYP3A4 (minor);",
"     <b>",
"      Note:",
"     </b>",
"     Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential;",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP2B6 (weak), CYP2C19 (weak), CYP2C9 (weak), CYP2D6 (weak), CYP3A4 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F7976977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Alcohol (Ethyl): May enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Amphetamines: May diminish the sedative effect of Antihistamines.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: May enhance the adverse/toxic effect of other Anticholinergics.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Levocabastine (Nasal).",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP3A4 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ARIPiprazole: CYP2D6 Inhibitors (Weak) may increase the serum concentration of ARIPiprazole.  Management: Monitor for increased aripiprazole pharmacologic effects. Aripiprazole dose adjustments may or may not be required based on concomitant therapy and/or indication. Consult full interaction monograph for specific recommendations.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Benzylpenicilloyl Polylysine: Antihistamines may diminish the diagnostic effect of Benzylpenicilloyl Polylysine.  Management: Suspend systemic H1 antagonists for benzylpenicilloyl-polylysine skin testing and delay testing until systemic antihistaminic effects have dissipated. A histamine skin test may be used to assess persistent antihistaminic effects.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Betahistine: Antihistamines may diminish the therapeutic effect of Betahistine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Buprenorphine: CNS Depressants may enhance the CNS depressant effect of Buprenorphine.  Management: Consider reduced doses of CNS depressants used in combination with buprenorphine.  Consider avoiding other CNS depressants in patients thought to be at high risk of buprenorphine overuse or self-injection.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CNS Depressants: May enhance the CNS depressant effect of Azelastine (Nasal).",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Droperidol: May enhance the CNS depressant effect of CNS Depressants. Management: Consider dose reductions of droperidol or of other CNS agents (e.g., opioids, barbiturates) with concomitant use.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Hyaluronidase: Antihistamines may diminish the therapeutic effect of Hyaluronidase.  Management: Patients receiving antihistamines (particularly at larger doses) may not experience the desired clinical response to standard doses of hyaluronidase.  Larger doses of hyaluronidase may be required.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     HydrOXYzine: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium (Oral Inhalation): May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Lomitapide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Lomitapide.  Management: Limit the maximum adult dose of lomitapide to 30 mg daily when used in combination with any weak CYP3A4 inhibitor.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Sulfate: May enhance the CNS depressant effect of CNS Depressants.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methotrimeprazine: CNS Depressants may enhance the CNS depressant effect of Methotrimeprazine. Methotrimeprazine may enhance the CNS depressant effect of CNS Depressants.  Management: Reduce adult dose of CNS depressant agents by 50% with initiation of concomitant methotrimeprazine therapy. Further CNS depressant dosage adjustments should be initiated only after clinically effective methotrimeprazine dose is established.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Metyrosine: CNS Depressants may enhance the sedative effect of Metyrosine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirtazapine: CNS Depressants may enhance the CNS depressant effect of Mirtazapine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Paraldehyde: CNS Depressants may enhance the CNS depressant effect of Paraldehyde.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Peginterferon Alfa-2b: May decrease the serum concentration of CYP2D6 Substrates.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Perampanel: May enhance the CNS depressant effect of CNS Depressants. Management: Patients taking perampanel with any other drug that has CNS depressant activities should avoid complex and high-risk activities, particularly those such as driving that require alertness and coordination, until they have experience using the combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pimozide: CYP3A4 Inhibitors (Weak) may increase the serum concentration of Pimozide.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramipexole: CNS Depressants may enhance the sedative effect of Pramipexole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ROPINIRole: CNS Depressants may enhance the sedative effect of ROPINIRole.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Rotigotine: CNS Depressants may enhance the sedative effect of Rotigotine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Selective Serotonin Reuptake Inhibitors: CNS Depressants may enhance the adverse/toxic effect of Selective Serotonin Reuptake Inhibitors. Specifically, the risk of psychomotor impairment may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Oxybate: May enhance the CNS depressant effect of CNS Depressants. Management: Consider alternatives to combined use. When combined use is needed, consider minimizing doses of one or more drugs. Use of sodium oxybate with alcohol or sedative hypnotics is contraindicated.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zolpidem: CNS Depressants may enhance the CNS depressant effect of Zolpidem.  Management: Reduce the Intermezzo brand sublingual zolpidem dose to 1.75 mg for men who are also receiving other CNS depressants.  No such dose change is recommended for women.  Avoid use with other CNS depressants at bedtime; avoid use with alcohol.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block foi drugH1Div\" id=\"F7976981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Ethanol/Nutrition/Herb Interactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Ethanol: May increase CNS depression; monitor for increased effects with coadministration. Caution patients about effects.",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F7976963\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F7976964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have shown toxic effects to the fetus at maternally toxic doses.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F7976966\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F7977057\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Astelin Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     137 mcg/spray (30 mL): $161.92",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Astepro Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     0.15% (30 mL): $147.34",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Azelastine HCl Nasal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     137 mcg/spray (30 mL): $105.20",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F10961953\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Afluon (GR);",
"     </li>",
"     <li>",
"      Allergodil (AT, BE, BG, CH, CZ, DE, DK, EE, FR, HN, IT, NL, PL, PT, RU, TR, VE);",
"     </li>",
"     <li>",
"      Astelin (PK);",
"     </li>",
"     <li>",
"      Azela (PH, TW);",
"     </li>",
"     <li>",
"      Azelan (KP);",
"     </li>",
"     <li>",
"      Azelvin (NO, SE);",
"     </li>",
"     <li>",
"      Azep (CL, IN, NZ, SG);",
"     </li>",
"     <li>",
"      Azep Nasal Spray (AU, NZ);",
"     </li>",
"     <li>",
"      Azetin (TW);",
"     </li>",
"     <li>",
"      Lastin (FI, NO, SE);",
"     </li>",
"     <li>",
"      Min Qi (CL);",
"     </li>",
"     <li>",
"      Otrivin (CH);",
"     </li>",
"     <li>",
"      Otrivine Anti-Allergie (BE);",
"     </li>",
"     <li>",
"      Rhinolast (IL, PK);",
"     </li>",
"     <li>",
"      Rinalin (DO, GT, NI, PA, SV);",
"     </li>",
"     <li>",
"      Rino-Lastin (BR)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F7977028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Competes with histamine for H",
"     <sub>",
"      1",
"     </sub>",
"     -receptor sites on effector cells and inhibits the release of histamine and other mediators involved in the allergic response; when used intranasally, reduces hyper-reactivity of the airways; increases the motility of bronchial epithelial cilia, improving mucociliary transport",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F7977030\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Peak effect: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Duration: 12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Following application of the nasal spray, peak plasma concentrations are 200 pg/mL (0.1% solution) and 409 pg/mL (0.15% solution)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     : 14.5 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: Azelastine: 88%; Desmethylazelastine: 97%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Hepatic via CYP; active metabolite, desmethylazelastine",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: 40%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: Azelastine: 22-25 hours; Desmethylazelastine: 52-57 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, serum: 2-4 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Feces (75 %, &lt;10% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Dykewicz MS, Fineman S, Nicklas R, et al, &ldquo;Diagnosis and Management of Rhinitis: Complete Guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology,&rdquo;",
"      <i>",
"       Ann Allergy Asthma Immunol",
"      </i>",
"      , 1998, 81(5 Pt 2):478-518.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8022/abstract-text/9860027/pubmed\" id=\"9860027\" target=\"_blank\">",
"        9860027",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Wallace DV, Dykewicz MS, Bernstein DI, et al, &ldquo;The Diagnosis and Management of Rhinitis: An Updated Practice Parameter,&rdquo;",
"      <i>",
"       J Allergy Clin Immunol",
"      </i>",
"      , 2008, 122(2 Suppl):1-84.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?7/53/8022/abstract-text/18662584/pubmed\" id=\"18662584\" target=\"_blank\">",
"        18662584",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8674 Version 45.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-EFD95E538C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8022=[""].join("\n");
var outline_f7_53_8022=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976934\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976935\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976939\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977043\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977042\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977044\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15794418\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F15794419\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977055\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976937\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977046\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976942\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976926\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976971\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976967\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976968\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976976\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976977\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976981\">",
"      Ethanol/Nutrition/Herb Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976963\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976964\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7976966\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977057\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10961953\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977028\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7977030\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8674\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8674|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?11/54/12132?source=related_link\">",
"      Azelastine (nasal): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?5/20/5445?source=related_link\">",
"      Azelastine (nasal): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/47/17139?source=related_link\">",
"      Azelastine (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/17/38164?source=related_link\">",
"      Azelastine (ophthalmic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/19/31026?source=related_link\">",
"      Azelastine (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_53_8023="Mixed histology thymoma";
var content_f7_53_8023=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F50356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F50356&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mixed lymphoepithelial, spindle cell-type thymoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 231px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The epithelial cells display a spindled appearance with fascicular architecture. (Hematoxylin and eosin, magnification 50x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8023=[""].join("\n");
var outline_f7_53_8023=null;
var title_f7_53_8024="Influence of cytokines on gut immune homeostasis";
var content_f7_53_8024=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74195&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 591px\">",
"   <div class=\"ttl\">",
"    Influence of cytokines on gut immune homeostasis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 571px; height: 433px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Neutrophil recruitment to the intestinal lamina propria in the early stages of inflammation is induced by IL-8, a chemokine secreted by macrophages. Interleukin (IL)-1 production can be stimulated by pro-inflammatory cytokines including tumor necrosis factor (TNF)-beta and IL-1-beta. Luminal antigen sampling by dendritic cells (DCs) occurs via transepithelial dendrite extensions, a process that depends on the CX3CR1 fractalkine receptor. Antigen-presenting cells including DCs drive type 1 T helper cell (Th1), Th17, or Th2 differentiation through the secretion of IL-12, IL-18, IL-27 (Th1) or IL-23, IL-6, transforming growth factor (TGF)-beta (Th17) or IL-4, and IL-27 (Th2). T effector cells secrete pro-inflammatory cytokines that lead to inflammation. CD1d-restricted natural killer (NK) T cells secrete IL-13 upon activation and lead to Th2 cytokine secretion. Suppression of inflammation can occur through naturally occurring thymic-derived Foxp3+ regulatory cells (Foxp3+ Treg), IL-10 producing T cells, or TGF-beta secreting T cells (Th3). Suppressive Foxp3+ T cells can also arise from Foxp3- T cells upon retinoic acid and TGF-beta stimulation via CD103+ DCs. NK cells have anti-inflammatory properties through the secretion of the suppressive cytokine IL-22. T-bet, GATA-3, ROR-gamma-t, and Foxp3 are transcription factors involved in Th1, Th2, Th17, and Treg differentiation, respectively.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Maillard MH, Snapper SB. Cytokines and chemokines in mucosal homeostasis. In: Inflammatory Bowel Diseases: Translating Basic Science into Clinical Practice, Targan SR, Shanahan F, Karp LC (Eds), Wiley-Blackwell, Oxford, UK 2010. Copyright &copy; 2010 Wiley-Blackwell.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8024=[""].join("\n");
var outline_f7_53_8024=null;
var title_f7_53_8025="CPAM type 2 histology";
var content_f7_53_8025=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66962&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histology of type 2 congenital pulmonary airway malformation (CPAM)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 284px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Histologic specimen of a type 2 congenital pulmonary airway malformation (CPAM). The lesion is composed of structures resembling terminal bronchioles and is lined by low columnar to cuboidal epithelium. These structures are separated by small amounts of connective tissue. In this example, alveolar structures are not apparent.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Christopher M Oermann, MD, and Claire Langston, MD",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8025=[""].join("\n");
var outline_f7_53_8025=null;
var title_f7_53_8026="Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults";
var content_f7_53_8026=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Epidemiology of methicillin-resistant Staphylococcus aureus infection in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Deverick J Anderson, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Daniel J Sexton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?7/53/8026/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?7/53/8026/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 3, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Methicillin-resistant Staphylococcus aureus (MRSA) was described in 1961, shortly after the introduction of methicillin, and outbreaks of MRSA were reported in the early 1960s [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Since that time, MRSA has spread worldwide, and the prevalence of MRSA has increased in both healthcare and community settings. For example, the prevalence of methicillin-resistance among S. aureus isolates in intensive care units in the United States is 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/3\">",
"     3",
"    </a>",
"    ], and more than 90,000 invasive infections due to MRSA occurred in the United States in 2005 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Methicillin resistance is mediated by PBP-2a, a penicillin binding protein encoded by the mecA gene that permits the organism to grow and divide in the presence of methicillin and other beta-lactam antibiotics. The mecA gene is located on a mobile genetic element called staphylococcal chromosome cassette (SCCmec). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A single clone probably accounted for most MRSA isolates recovered during the 1960s; by 2004, six major MRSA clones emerged worldwide, labeled as SCCmec I-VI [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/5-9\">",
"     5-9",
"    </a>",
"    ]. Dissemination of resistance was mediated by horizontal transfer of the mecA gene and related regulatory sequences [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The epidemiology and clinical manifestations of MRSA infection in adults will be reviewed here. Prevention, control, and treatment of MRSA infections in adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=see_link\">",
"     \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4216?source=see_link\">",
"     \"Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthcare-associated methicillin-resistant S. aureus (HA-MRSA) and community-associated methicillin-resistant S. aureus (CA-MRSA) differ with respect to their clinical and molecular epidemiology.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Healthcare-associated methicillin-resistant Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;HA-MRSA is defined as MRSA infection that occurs &gt;48 hours following hospitalization (hospital-onset, HA-MRSA, formerly &ldquo;nosocomial&rdquo;) or MRSA infection that occurs outside of the hospital within 12 months of exposure to healthcare (eg, history of surgery, hospitalization, dialysis, or residence in a long-term care facility; community-onset, HA-MRSA) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/4\">",
"     4",
"    </a>",
"    ]. HA-MRSA is associated with severe, invasive disease, including skin and soft tissue infection, bloodstream infection (BSI), and pneumonia [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/4,11-14\">",
"     4,11-14",
"    </a>",
"    ]. In fact, MRSA is the leading cause of surgical site infection in both tertiary and community hospitals [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. HA-MRSA strains tend to have multidrug resistance and carry staphylococcal cassette chromosome type II (SCCmec type II) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/17\">",
"     17",
"    </a>",
"    ]. They are typified by a USA100 or USA200 pulse-field electrophoresis (PFGE) pattern [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/18\">",
"     18",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HA-MRSA has been a problem in hospital settings since the 1960s; there has since been a progressive increase in the prevalence of antimicrobial resistance in hospital-acquired S. aureus infections [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/3,11,19\">",
"     3,11,19",
"    </a>",
"    ]. In a United States surveillance report of over 24,000 cases of hospital-acquired S. aureus BSIs, isolates with methicillin resistance increased from 22 to 57 percent between 1995 and 2001 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/11\">",
"     11",
"    </a>",
"    ]. Worldwide, HA-MRSA prevalence varies considerably, from &lt;1 percent in Scandinavia to up to 40 percent in Japan, Israel, and elsewhere in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRSA is one of the few pathogens routinely implicated in nearly every type of hospital-acquired infection. This is probably related in part to the organism's capacity for biofilm formation on invasive, foreign devices such as endotracheal tubes and urinary and endovascular catheters [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/22\">",
"     22",
"    </a>",
"    ]. Biofilm facilitates MRSA survival and multiplication on these surfaces, prolonging the duration of organism exposure to antibiotics as well as promoting the potential opportunity for transfer of antibiotic resistance genes between organisms [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for HA-MRSA infection include antibiotic use, prolonged hospitalization, intensive care, hemodialysis, MRSA colonization, and proximity to others with MRSA colonization or infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/24-26\">",
"     24-26",
"    </a>",
"    ]. Risk of MRSA infection related to antibiotic use, hemodialysis, and colonization are discussed in further detail below. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Risk factors'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H14\">",
"     'Colonization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with MRSA infection have higher mortality, longer hospital stays, and higher healthcare costs than patients with methicillin-susceptible S. aureus (MSSA) infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/14,27-30\">",
"     14,27-30",
"    </a>",
"    ]. For example, two meta-analyses including data on approximately 4000 patients demonstrated that patients with BSI due to MRSA were 1.5- to 2.0-fold more likely to die than patients with BSI due to MSSA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/14,31\">",
"     14,31",
"    </a>",
"    ]. Patients with infection due to MRSA also have higher rates of acute renal failure, hemodynamic instability, and prolonged ventilator dependency than patients with infection due to MSSA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Community-associated methicillin-resistant Staphylococcus aureus",
"    </span>",
"    &nbsp;&mdash;&nbsp;CA-MRSA is defined as MRSA infection that occurs in the absence of healthcare exposure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/4\">",
"     4",
"    </a>",
"    ]. CA-MRSA is most often associated with skin and soft tissue infections in young, otherwise healthy individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/23\">",
"     23",
"    </a>",
"    ]. Most CA-MRSA strains are sensitive to non-beta-lactam antibiotics, although a multidrug-resistant isolate has been described among men who have sex with men [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/32,33\">",
"     32,33",
"    </a>",
"    ]. This strain contains the pUSA03 plasmid and carries resistance genes for beta-lactams, fluoroquinolones,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?2/49/2840?source=see_link\">",
"     tetracycline",
"    </a>",
"    , macrolides,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/21/33104?source=see_link\">",
"     clindamycin",
"    </a>",
"    , and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/30/33252?source=see_link\">",
"     mupirocin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most CA-MRSA strains frequently carry staphylococcal cassette chromosome (SCCmec) type IV or V, and frequently carry genes for the cytotoxin Panton-Valentine leukocidin that confers enhanced virulence [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/33-38\">",
"     33-38",
"    </a>",
"    ]. Most CA-MRSA are typified by a USA300 or USA400 pulse-field electrophoresis (PFGE) pattern. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CA-MRSA was initially reported among injection drug users in the early 1980s [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/39\">",
"     39",
"    </a>",
"    ] and has since become the most frequent cause of skin and soft tissue infections presenting to United States emergency departments and ambulatory clinics [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. This was illustrated by a prospective study of 422 patients with skin and soft tissue infections (SSTI) seen in emergency departments in August 2004; S. aureus was implicated in 76 percent of cases, 97 percent of these isolates were the CA-MRSA USA300 strain, and 98 percent possessed the Panton-Valentine leukocidin toxin gene [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/40\">",
"     40",
"    </a>",
"    ]. USA300 appears to be more transmissible among household members than other S. aureus genetic backgrounds [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/42\">",
"     42",
"    </a>",
"    ]. SSTI due to USA300 is a risk factor for bloodstream infection due to USA300, as is use of an antimicrobial with activity against MRSA in the preceding 30 days [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Community outbreaks have been reported in multiple settings, including native and aboriginal communities, sports teams, child care centers, military personnel, men who have sex with men, and prison inmates and guards [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/32,44-58\">",
"     32,44-58",
"    </a>",
"    ]. These observations have led to identification of some risk factors with relatively poor predictive value for CA-MRSA. These include skin trauma (eg, lacerations, abrasions, tattoos, injection drug use), cosmetic body shaving, incarceration, sharing equipment that is not cleaned or laundered between users, and close contact with others who have MRSA colonization or infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/23,44,46,48-55,59\">",
"     23,44,46,48-55,59",
"    </a>",
"    ]. Animals can also carry MRSA and function as a source of transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/60-62\">",
"     60-62",
"    </a>",
"    ]. Importantly, many patients with CA-MRSA have no risk factors [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Skin and soft tissue remain the predominant sites of CA-MRSA infection, although it can also cause invasive, severe disease such as necrotizing pneumonia, osteomyelitis, urinary tract infection, infective endocarditis, and sepsis (with or without Waterhouse-Friderichson syndrome) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/23,56,64-69\">",
"     23,56,64-69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=see_link&amp;anchor=H18#H18\">",
"     \"Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults\", section on 'S. aureus'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Evolving epidemiologic observations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The CA-MRSA and HA-MRSA classifications are no longer distinct, since patients can develop MRSA colonization in one realm and develop manifestations of infection in another [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/63,70-75\">",
"     63,70-75",
"    </a>",
"    ]. In the mid-2000s in San Francisco, the annual incidence of CA-MRSA surpassed that of HA-MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Community-onset, HA-MRSA infections have been observed with increasing frequency among patients in community settings. This was illustrated in a study of 209 patients discharged from hospitalized care; within 18 months following hospital discharge, 49 percent of new MRSA infections began outside the hospital [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/77\">",
"     77",
"    </a>",
"    ]. In another series of 102 patients with CA-MRSA infections, 29 percent had molecular typing consistent with HA-MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Similarly, patients with MRSA infections due to &ldquo;community-associated&rdquo; strains have also been observed with increasing frequency among patients in hospital settings. CA-MRSA strains may also cause hospital-onset, healthcare-associated infections, since patients who become colonized with CA-MRSA strains in the community may require hospitalization and either transmit such strains to other hospitalized patients or develop infection while hospitalized (eg, following surgery or insertion of an invasive device) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/78\">",
"     78",
"    </a>",
"    ]. In a review of 352 patients with &ldquo;healthcare-associated&rdquo; MRSA acquired, the proportion of isolates with CA-MRSA molecular typing increased from 17 to 56 percent between 1999 and 2004 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The blurring epidemiologic distinction between HA-MRSA and CA-MRSA was also illustrated by the United States Active Bacterial Core surveillance network report of 8987 invasive MRSA infections in 2005. In this report, the rate of invasive MRSA infection was 32 per 100,000, the incidence of MRSA among patients &ge;65 was 128 per 100,000 and the mortality rate was 6.3 per 100,000 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/4\">",
"     4",
"    </a>",
"    ]. By extrapolation from these data, the authors estimated that in 2005 in the United States there were 94,360 cases of invasive MRSA infection with 18,650 deaths. Of those, 27 percent were HA-MRSA infections with onset in the hospital, 58 percent were associated with healthcare and occurred within one year of a medical procedure (HA-MRSA infections with community-onset), and 14 percent were community-acquired infections. The authors concluded that MRSA infections are primarily related to healthcare but are no longer confined to intensive care units, acute care hospitals, or any health care institution.",
"   </p>",
"   <p>",
"    In addition, CA-MRSA may be replacing traditional hospital-acquired strains. Molecular typing of 208 isolates from hospital-onset, HA-MRSA BSIs between 2000 and 2006 demonstrated that although the total number of MRSA BSIs was stable, community-acquired strains were responsible for an increasing proportion of cases (from 24 to 49 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Rates of invasive healthcare-associated MRSA infections appear to be decreasing between 2005 and 2010 both among patients with healthcare-associated infections that began in the community, as well as among patients with hospital-onset invasive disease [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. The proportion of community onset soft tissue infections due to MRSA also decreased between 2005 and 2010 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/81\">",
"     81",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Linezolid resistance",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?14/3/14393?source=see_link\">",
"     Linezolid",
"    </a>",
"    resistance has been observed among methicillin-resistant S. aureus isolates. The mechanism appears to be via the bacterial cfr gene, which resides in a potentially mobile genetic element [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/82\">",
"     82",
"    </a>",
"    ]. Clinical outbreaks of linezolid-resistant S. aureus (LRSA) have been described; reduction of linezolid use and infection control measures were associated with termination of the outbreaks [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/83,84\">",
"     83,84",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Colonization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Colonization with S. aureus raises the risk for staphylococcal infection after invasive medical or surgical procedures. Screening of hospital patients and subsequent treatment to eliminate carriage before infection develops have focused on the nares, which are the primary colonization site for this pathogen.",
"   </p>",
"   <p>",
"    The National Health and Nutrition Examination Survey (NHANES) noted that the prevalence of MRSA nasal colonization in 2003-2004 was 1.5 percent, up from 0.8 percent in 2001-2002 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/85\">",
"     85",
"    </a>",
"    ]. About 19 percent of MRSA colonized individuals carried a PFGE type associated with community transmission. The relatively low prevalence of the CA-MRSA strains in this study raises some interesting questions given the ongoing epidemic of CA-MRSA skin and soft-tissue infections; CA-MRSA may cause disease without previous nasal colonization,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    favor other sites of colonization over the nares (such as the skin, throat, or gastrointestinal tract). Among healthcare workers, the prevalence of MRSA nasal colonization is 4 to 15 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/86,87\">",
"     86,87",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, some individuals are colonized only in the throat, and such individuals would be missed on routine nasal screening. Among the 3464 Swiss patients, 48 percent were S. aureus carriers; 12 percent had exclusive throat carriage [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/88\">",
"     88",
"    </a>",
"    ]. These data suggest an important limitation for screening programs based on nasal cultures alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The dramatic increase in methicillin-resistant S. aureus (MRSA) prevalence in hospital and community settings has been attributed to multiple factors [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/22,89\">",
"     22,89",
"    </a>",
"    ]. Risk factors for healthcare-associated methicillin-resistant S. aureus (HA-MRSA) and community-associated methicillin-resistant S. aureus (CA-MRSA) are described above (",
"    <a class=\"graphic graphic_table graphicRef53504 \" href=\"UTD.htm?5/9/5275\">",
"     table 1",
"    </a>",
"    ). More detailed discussions related to antibiotic use, HIV-infected individuals, hemodialysis, and long-term care facilities will be reviewed in this section.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14500218\">",
"    <span class=\"h2\">",
"     Methicillin-resistant Staphylococcus aureus infection",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Antibiotic use",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRSA probably arose due to antibiotic selective pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/1,22\">",
"     1,22",
"    </a>",
"    ]. Antibiotic use (particularly cephalosporin and fluoroquinolone use) strongly correlates with the risk for MRSA colonization and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/7,12,17,90-93\">",
"     7,12,17,90-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a case-control study including 1981 cases of MRSA, the risk for MRSA increased with the number of antimicrobial agents; the odds ratios (OR) for MRSA diagnosis in patients who were prescribed 1, 2&ndash;3, or &ge;4 antimicrobial drugs were 1.57, 2.46, and 6.24, respectively. The highest risk was for fluoroquinolones (OR 3.37) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/93\">",
"     93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cephalosporins were implicated in a case-control study of 387 patients with S. aureus infection (half with MRSA and half with methicillin-susceptible S. aureus [MSSA]); patients who had received cephalosporins for &ge;5 days were three times more likely to acquire MRSA than those who had not received cephalosporins [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/91,92\">",
"     91,92",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV-infected individuals are at increased risk for MRSA colonization and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/94-97\">",
"     94-97",
"    </a>",
"    ]. In a case-control surveillance study of MRSA colonization among 726 patients, HIV was an important risk factor for colonization (OR 3.3) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/94\">",
"     94",
"    </a>",
"    ]. HIV is also a risk factor for MRSA infection; in a retrospective study of 3455 HIV patients, the incidence of MRSA infection was nearly 5 per 100 patient-years; the incidence of MRSA infection had increased sixfold between 2000 and 2003 [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/95\">",
"     95",
"    </a>",
"    ]. The primary sites of these infections were skin and soft tissue (83 percent). Risk factors included advanced immunosuppression (CD4 count &lt;50",
"    <span class=\"nowrap\">",
"     cells/microL),",
"    </span>",
"    high plasma HIV RNA (&gt;100,000",
"    <span class=\"nowrap\">",
"     copies/microL),",
"    </span>",
"    and lack of antiretroviral therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Hemodialysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with long-term catheters for hemodialysis access are at significantly higher risk for invasive catheter-related infections due to MRSA and other pathogens. For example, in a review of 5287 cases of invasive MRSA infection, 15 percent occurred in dialysis patients; in fact, the incidence of invasive MRSA infection was 100 times higher among dialysis patients than in the general population (45 versus 0.4 per 1000 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/98\">",
"     98",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Long-term care facilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;HA-MRSA is prevalent among residents of long-term care facilities [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/99\">",
"     99",
"    </a>",
"    ]. For example, S. aureus accounted for about 15 percent of acquired infections in a five year observational study of a 120-bed nursing facility; roughly half were due to MRSA. In addition, MRSA-colonized residents are frequently transferred between hospitals and long-term care facilities, creating an ongoing circuit of MRSA transmission in areas where these organisms are prevalent.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14500258\">",
"    <span class=\"h2\">",
"     Methicillin-resistant Staphylococcus aureus infection with high vancomycin MIC",
"    </span>",
"    &nbsp;&mdash;&nbsp;Increased mortality and treatment failure have been reported in patients treated with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    for MRSA bacteremia when their isolates have elevated MIC. Risk factors that predict vancomycin MIC of 2",
"    <span class=\"nowrap\">",
"     mcg/mL",
"    </span>",
"    include age &gt;50 years, administration of vancomycin for &gt;48 hours in the week prior to bacteremia, chronic liver disease, history of MRSA bacteremia, and presence of a central line [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/100\">",
"     100",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16425?source=see_link\">",
"     \"Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional data suggest that increased risk for treatment failure among patients with HA-MRSA infections compared with CA-MRSA may be independent of the",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/41/42649?source=see_link\">",
"     vancomycin",
"    </a>",
"    MIC, suggesting a potential intrinsic strain-specific defect [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/101\">",
"     101",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=see_link\">",
"     \"Microbiology of methicillin-resistant Staphylococcus aureus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     TRANSMISSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Healthcare-associated methicillin-resistant S. aureus (HA-MRSA) strains are most commonly transmitted to patients via the transiently contaminated hands of healthcare workers. Hospitalized patients may also acquire HA-MRSA from contaminated environmental surfaces. Community-associated methicillin-resistant S. aureus (CA-MRSA) strains are most commonly transmitted by direct contact with a colonized or infected individual.",
"   </p>",
"   <p>",
"    Individuals in the community may also acquire CA-MRSA by contact with contaminated fomites used by an affected individual. Among 188 household contacts of 148 patients known to be colonized with MRSA prior to hospital discharge, 19 percent acquired MRSA colonization, though none developed MRSA infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/102\">",
"     102",
"    </a>",
"    ]. Older age and providing healthcare to the discharged patient were associated with MRSA acquisition. Adherence to infection control measures is critical for interrupting MRSA transmission. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=see_link\">",
"     \"General principles of infection control\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=see_link\">",
"     \"Prevention and control of methicillin-resistant Staphylococcus aureus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Colonization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Individuals colonized with MRSA serve as a reservoir for transmission. MRSA can colonize the skin and nares of hospitalized patients, health care workers, and healthy individuals (up to 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/26,94,103-105\">",
"     26,94,103-105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Colonization increases the risk for MRSA infection. In a study of 758 patients for whom nares cultures were obtained on hospital admission [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/3\">",
"     3",
"    </a>",
"    ], the rate of MRSA infection in the year following admission was substantially higher among those with baseline MRSA colonization than those without colonization (19 versus 2 percent, respectively).",
"   </p>",
"   <p>",
"    Colonization can occur in the following ways [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/1,106\">",
"     1,106",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Contact with contaminated wounds or dressings of infected patients",
"     </li>",
"     <li>",
"      Contact with another individual's colonized intact skin",
"     </li>",
"     <li>",
"      Contact with contaminated inanimate objects",
"     </li>",
"     <li>",
"      Inhalation of aerosolized droplets from chronic nasal carriers",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The anterior nares is the most common site of MRSA colonization [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/106-109\">",
"     106-109",
"    </a>",
"    ]. Individuals with nasal MRSA carriage transmit MRSA more readily in the setting of concomitant sinus infection or upper respiratory infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/110,111\">",
"     110,111",
"    </a>",
"    ]. A majority of individuals with nasal colonization are also colonized on other areas of intact skin including the hands, axillae, perineum, and umbilicus (in infants) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/106,108,112-114\">",
"     106,108,112-114",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other potential sites of MRSA colonization include surgical wounds, decubitus ulcers, intravascular catheter sites and other invasive devices, throat, sputum, stool and the genitourinary tract. In one study of 71 hospitalized patients with S. aureus colonization, 67 percent had colonization of the gastrointestinal tract, which was associated with increased frequency of S. aureus skin colonization [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/115\">",
"     115",
"    </a>",
"    ]. The durability of MRSA colonization can vary from a few days or weeks to up to several years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/107,116\">",
"     107,116",
"    </a>",
"    ]. In one prospective cohort study of 78 patients with MRSA colonization, the median duration of hospitalization was 8.5 months [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/117\">",
"     117",
"    </a>",
"    ]. Patients with breaks in skin were more likely to have longer duration of MRSA colonization than patients with intact skin (OR = 4.3, p = 0.004).",
"   </p>",
"   <p>",
"    The natural history of MRSA and methicillin-susceptible S. aureus (MSSA) colonization was evaluated in a 10-week prospective observational study of 812 soldiers [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/118\">",
"     118",
"    </a>",
"    ]. Baseline colonization rates with MRSA were lower than MSSA (3 versus 28 percent), but subsequent development of infection was higher among those with MRSA than MSSA colonization (38 versus 3 percent). The rate of CA-MRSA colonization fell to under 2 percent at 10-week follow-up.",
"   </p>",
"   <p>",
"    Individual MRSA colonization is an important risk factor for subsequent development of MRSA infection [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/26\">",
"     26",
"    </a>",
"    ]. In a review of 758 hospitalized patients, MRSA colonization was observed in 3.4 percent of admissions and acquired in an additional 3 percent; the rates of MRSA infection within one year in these groups were 19 and 25 percent (relative risks 9.5 and 13 compared with patients with no colonization or MSSA colonization, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/26\">",
"     26",
"    </a>",
"    ]. Previously colonized patients should be considered to be at risk of continued carriage for at least four years [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/119\">",
"     119",
"    </a>",
"    ]. Among 1564 MRSA carriers, the prevalence of colonization was observed to decrease rapidly to 48 percent at one year; thereafter, rates of colonization remained high for prolonged periods, as 21 percent remained colonized at four years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Contaminated environmental surfaces",
"    </span>",
"    &nbsp;&mdash;&nbsp;MRSA-contaminated surfaces can serve as reservoirs for MRSA transmission [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/120-122\">",
"     120-122",
"    </a>",
"    ]. In a prospective culture survey of a 200-bed hospital, cultures obtained from the hospital room inanimate surfaces of MRSA-infected patients were positive more frequently in the setting of wound infections or urinary tract infections than in the setting MRSA infection at other sites (36 versus 6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/120\">",
"     120",
"    </a>",
"    ]. In another study, environmental surfaces in the rooms of patients with heavy gastrointestinal MRSA colonization and diarrhea were contaminated in 59 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/123\">",
"     123",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRSA may also be transmissible between healthcare workers via medical equipment. In a study of cultures from 200 stethoscope ear tips, 80 percent were contaminated with microorganisms. Among the positive cultures, 58 percent were Staphylococcus species, and 17 percent were MRSA [",
"    <a class=\"abstract\" href=\"UTD.htm?7/53/8026/abstract/121\">",
"     121",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/4/22595?source=see_link\">",
"       \"Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Healthcare-associated methicillin-resistant Staphylococcus aureus (HA-MRSA) is associated with severe, invasive disease in hospitalized patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Healthcare-associated methicillin-resistant Staphylococcus aureus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Community-associated methicillin-resistant S. aureus (CA-MRSA) is most often associated with skin and soft tissue infections in young, healthy individuals with no recent healthcare exposure. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Community-associated methicillin-resistant Staphylococcus aureus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Though convenient epidemiologic terms, the line between &ldquo;HA-&rdquo; and &ldquo;CA-&rdquo; MRSA is significantly blurred. Patients can develop MRSA colonization in one realm and develop manifestations of infection in another or simply introduce MRSA in the second realm. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Evolving epidemiologic observations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Risk factors for infection due to HA-MRSA include antibiotic use, prolonged hospitalization, intensive care, invasive devices, hemodialysis, MRSA colonization, and proximity to others with MRSA colonization or infection. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Healthcare-associated methicillin-resistant Staphylococcus aureus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Additional risk factors for CA-MRSA infection include skin trauma (eg, lacerations, abrasions, tattoos, injection drug use), cosmetic body shaving, incarceration, HIV infection, and sharing equipment that is not cleaned or laundered between users. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Community-associated methicillin-resistant Staphylococcus aureus'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Risk factors'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MRSA transmission occurs via contact with a colonized individual or a contaminated fomite. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Transmission'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/1\">",
"      BARBER M. Methicillin-resistant staphylococci. J Clin Pathol 1961; 14:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/2\">",
"      Benner EJ, Kayser FH. Growing clinical significance of methcillin-resistant Staphylococcus aureus. Lancet 1968; 2:741.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/3\">",
"      National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004; 32:470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/4\">",
"      Klevens RM, Morrison MA, Nadle J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298:1763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/5\">",
"      Kreiswirth B, Kornblum J, Arbeit RD, et al. Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 1993; 259:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/6\">",
"      Cris&oacute;stomo MI, Westh H, Tomasz A, et al. The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl Acad Sci U S A 2001; 98:9865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/7\">",
"      Enright MC, Robinson DA, Randle G, et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci U S A 2002; 99:7687.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/8\">",
"      Ito T, Ma XX, Takeuchi F, et al. Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC. Antimicrob Agents Chemother 2004; 48:2637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/9\">",
"      Oliveira DC, Tomasz A, de Lencastre H. The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. Microb Drug Resist 2001; 7:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/10\">",
"      Archer GL, Niemeyer DM, Thanassi JA, Pucci MJ. Dissemination among staphylococci of DNA sequences associated with methicillin resistance. Antimicrob Agents Chemother 1994; 38:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/11\">",
"      Wisplinghoff H, Bischoff T, Tallent SM, et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/12\">",
"      Boyce JM. Methicillin-resistant Staphylococcus aureus in hospitals and long-term care facilities: microbiology, epidemiology, and preventive measures. Infect Control Hosp Epidemiol 1992; 13:725.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/13\">",
"      Klevens RM, Edwards JR, Tenover FC, et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 2006; 42:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/14\">",
"      Cosgrove SE, Sakoulas G, Perencevich EN, et al. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003; 36:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/15\">",
"      Anderson DJ, Sexton DJ, Kanafani ZA, et al. Severe surgical site infection in community hospitals: epidemiology, key procedures, and the changing prevalence of methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol 2007; 28:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/16\">",
"      Hidron AI, Edwards JR, Patel J, et al. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008; 29:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/17\">",
"      Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003; 290:2976.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/18\">",
"      McDougal LK, Steward CD, Killgore GE, et al. Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database. J Clin Microbiol 2003; 41:5113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/19\">",
"      Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006; 5:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/20\">",
"      Sader HS, Streit JM, Fritsche TR, Jones RN. Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin Microbiol Infect 2006; 12:844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/21\">",
"      Voss A, Milatovic D, Wallrauch-Schwarz C, et al. Methicillin-resistant Staphylococcus aureus in Europe. Eur J Clin Microbiol Infect Dis 1994; 13:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/22\">",
"      Shorr AF. Epidemiology of staphylococcal resistance. Clin Infect Dis 2007; 45 Suppl 3:S171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/23\">",
"      Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005; 352:1436.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/24\">",
"      Thompson RL, Cabezudo I, Wenzel RP. Epidemiology of nosocomial infections caused by methicillin-resistant Staphylococcus aureus. Ann Intern Med 1982; 97:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/25\">",
"      Boyce JM. Methicillin-resistant Staphylococcus aureus. Detection, epidemiology, and control measures. Infect Dis Clin North Am 1989; 3:901.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/26\">",
"      Davis KA, Stewart JJ, Crouch HK, et al. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 2004; 39:776.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/27\">",
"      Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002; 162:2229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/28\">",
"      Cosgrove SE, Qi Y, Kaye KS, et al. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005; 26:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/29\">",
"      Reed SD, Friedman JY, Engemann JJ, et al. Costs and outcomes among hemodialysis-dependent patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005; 26:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/30\">",
"      Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/31\">",
"      Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: a meta-analysis. Med J Aust 2001; 175:264.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/32\">",
"      Diep BA, Chambers HF, Graber CJ, et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/33\">",
"      Diep BA, Gill SR, Chang RF, et al. Complete genome sequence of USA300, an epidemic clone of community-acquired meticillin-resistant Staphylococcus aureus. Lancet 2006; 367:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/34\">",
"      Baba T, Takeuchi F, Kuroda M, et al. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet 2002; 359:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/35\">",
"      Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and community-associated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis 2006; 193:1495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/36\">",
"      Ma XX, Ito T, Tiensasitorn C, et al. Novel type of staphylococcal cassette chromosome mec identified in community-acquired methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother 2002; 46:1147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/37\">",
"      Tenover FC, McDougal LK, Goering RV, et al. Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J Clin Microbiol 2006; 44:108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/38\">",
"      King MD, Humphrey BJ, Wang YF, et al. Emergence of community-acquired methicillin-resistant Staphylococcus aureus USA 300 clone as the predominant cause of skin and soft-tissue infections. Ann Intern Med 2006; 144:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/39\">",
"      Saravolatz LD, Markowitz N, Arking L, et al. Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a community-acquired outbreak. Ann Intern Med 1982; 96:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/40\">",
"      Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med 2006; 355:666.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/41\">",
"      Hersh AL, Chambers HF, Maselli JH, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168:1585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/42\">",
"      Miller LG, Eells SJ, Taylor AR, et al. Staphylococcus aureus colonization among household contacts of patients with skin infections: risk factors, strain discordance, and complex ecology. Clin Infect Dis 2012; 54:1523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/43\">",
"      Tattevin P, Schwartz BS, Graber CJ, et al. Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2012; 55:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/44\">",
"      Groom AV, Wolsey DH, Naimi TS, et al. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001; 286:1201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/45\">",
"      Byrd KK, Holman RC, Bruce MG, et al. Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis 2009; 49:1009.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/46\">",
"      Kazakova SV, Hageman JC, Matava M, et al. A clone of methicillin-resistant Staphylococcus aureus among professional football players. N Engl J Med 2005; 352:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/47\">",
"      Nguyen DM, Mascola L, Brancoft E. Recurring methicillin-resistant Staphylococcus aureus infections in a football team. Emerg Infect Dis 2005; 11:526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/48\">",
"      Begier EM, Frenette K, Barrett NL, et al. A high-morbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns. Clin Infect Dis 2004; 39:1446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/49\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant staphylococcus aureus infections among competitive sports participants--Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. MMWR Morb Mortal Wkly Rep 2003; 52:793.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/50\">",
"      Herold BC, Immergluck LC, Maranan MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998; 279:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/51\">",
"      Adcock PM, Pastor P, Medley F, et al. Methicillin-resistant Staphylococcus aureus in two child care centers. J Infect Dis 1998; 178:577.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/52\">",
"      Campbell KM, Vaughn AF, Russell KL, et al. Risk factors for community-associated methicillin-resistant Staphylococcus aureus infections in an outbreak of disease among military trainees in San Diego, California, in 2002. J Clin Microbiol 2004; 42:4050.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/53\">",
"      Aiello AE, Lowy FD, Wright LN, Larson EL. Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis 2006; 6:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/54\">",
"      From the Centers for Disease Control and Prevention. Public health dispatch: outbreaks of community-associated methicillin-resistant Staphylococcus aureus skin infections--Los Angeles County, California, 2002-2003. JAMA 2003; 289:1377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/55\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin or soft tissue infections in a state prison--Mississippi, 2000. MMWR Morb Mortal Wkly Rep 2001; 50:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/56\">",
"      Gilbert M, MacDonald J, Gregson D, et al. Outbreak in Alberta of community-acquired (USA300) methicillin-resistant Staphylococcus aureus in people with a history of drug use, homelessness or incarceration. CMAJ 2006; 175:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/57\">",
"      Lowy FD, Aiello AE, Bhat M, et al. Staphylococcus aureus colonization and infection in New York State prisons. J Infect Dis 2007; 196:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/58\">",
"      Turbeville SD, Cowan LD, Greenfield RA. Infectious disease outbreaks in competitive sports: a review of the literature. Am J Sports Med 2006; 34:1860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/59\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin infections among tattoo recipients--Ohio, Kentucky, and Vermont, 2004-2005. MMWR Morb Mortal Wkly Rep 2006; 55:677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/60\">",
"      Baptiste KE, Williams K, Willams NJ, et al. Methicillin-resistant staphylococci in companion animals. Emerg Infect Dis 2005; 11:1942.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/61\">",
"      Sing A, Tuschak C, H&ouml;rmansdorfer S. Methicillin-resistant Staphylococcus aureus in a family and its pet cat. N Engl J Med 2008; 358:1200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/62\">",
"      Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus skin infections from an elephant calf--San Diego, California, 2008. MMWR Morb Mortal Wkly Rep 2009; 58:194.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/63\">",
"      Miller LG, Perdreau-Remington F, Bayer AS, et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation. Clin Infect Dis 2007; 44:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/64\">",
"      Vayalumkal JV, Whittingham H, Vanderkooi O, et al. Necrotizing pneumonia and septic shock: suspecting CA-MRSA in patients presenting to Canadian emergency departments. CJEM 2007; 9:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/65\">",
"      Stankovic C, Mahajan PV, Asmar BI. Methicillin-resistant Staphylococcus aureus as a cause of community-acquired pneumonia. Curr Infect Dis Rep 2007; 9:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/66\">",
"      Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis 2007; 45:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/67\">",
"      Francis JS, Doherty MC, Lopatin U, et al. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005; 40:100.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/68\">",
"      Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza--Louisiana and Georgia, December 2006-January 2007. MMWR Morb Mortal Wkly Rep 2007; 56:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/69\">",
"      Wang JL, Chen SY, Wang JT, et al. Comparison of both clinical features and mortality risk associated with bacteremia due to community-acquired methicillin-resistant Staphylococcus aureus and methicillin-susceptible S. aureus. Clin Infect Dis 2008; 46:799.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/70\">",
"      Bancroft EA. Antimicrobial resistance: it's not just for hospitals. JAMA 2007; 298:1803.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/71\">",
"      Calfee DP, Durbin LJ, Germanson TP, et al. Spread of methicillin-resistant Staphylococcus aureus (MRSA) among household contacts of individuals with nosocomially acquired MRSA. Infect Control Hosp Epidemiol 2003; 24:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/72\">",
"      Seybold U, Kourbatova EV, Johnson JG, et al. Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis 2006; 42:647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/73\">",
"      Maree CL, Daum RS, Boyle-Vavra S, et al. Community-associated methicillin-resistant Staphylococcus aureus isolates causing healthcare-associated infections. Emerg Infect Dis 2007; 13:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/74\">",
"      Davis SL, Perri MB, Donabedian SM, et al. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007; 45:1705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/75\">",
"      David MZ, Glikman D, Crawford SE, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197:1235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/76\">",
"      Liu C, Graber CJ, Karr M, et al. A population-based study of the incidence and molecular epidemiology of methicillin-resistant Staphylococcus aureus disease in San Francisco, 2004-2005. Clin Infect Dis 2008; 46:1637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/77\">",
"      Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003; 36:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/78\">",
"      Otter JA, French GL. Nosocomial transmission of community-associated methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2006; 6:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/79\">",
"      Popovich KJ, Weinstein RA, Hota B. Are community-associated methicillin-resistant Staphylococcus aureus (MRSA) strains replacing traditional nosocomial MRSA strains? Clin Infect Dis 2008; 46:787.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/80\">",
"      Kallen AJ, Mu Y, Bulens S, et al. Health care-associated invasive MRSA infections, 2005-2008. JAMA 2010; 304:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/81\">",
"      Landrum ML, Neumann C, Cook C, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA 2012; 308:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/82\">",
"      Mendes RE, Deshpande LM, Castanheira M, et al. First report of cfr-mediated resistance to linezolid in human staphylococcal clinical isolates recovered in the United States. Antimicrob Agents Chemother 2008; 52:2244.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/83\">",
"      S&aacute;nchez Garc&iacute;a M, De la Torre MA, Morales G, et al. Clinical outbreak of linezolid-resistant Staphylococcus aureus in an intensive care unit. JAMA 2010; 303:2260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/84\">",
"      Bonilla H, Huband MD, Seidel J, et al. Multicity outbreak of linezolid-resistant Staphylococcus epidermidis associated with clonal spread of a cfr-containing strain. Clin Infect Dis 2010; 51:796.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/85\">",
"      Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008; 197:1226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/86\">",
"      Bisaga A, Paquette K, Sabatini L, Lovell EO. A prevalence study of methicillin-resistant Staphylococcus aureus colonization in emergency department health care workers. Ann Emerg Med 2008; 52:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/87\">",
"      Suffoletto BP, Cannon EH, Ilkhanipour K, Yealy DM. Prevalence of Staphylococcus aureus nasal colonization in emergency department personnel. Ann Emerg Med 2008; 52:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/88\">",
"      Mertz D, Frei R, Periat N, et al. Exclusive Staphylococcus aureus throat carriage: at-risk populations. Arch Intern Med 2009; 169:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/89\">",
"      Furuno JP, McGregor JC, Harris AD, et al. Identifying groups at high risk for carriage of antibiotic-resistant bacteria. Arch Intern Med 2006; 166:580.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/90\">",
"      MacDougall C, Powell JP, Johnson CK, et al. Hospital and community fluoroquinolone use and resistance in Staphylococcus aureus and Escherichia coli in 17 US hospitals. Clin Infect Dis 2005; 41:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/91\">",
"      Hill DA, Herford T, Parratt D. Antibiotic usage and methicillin-resistant Staphylococcus aureus: an analysis of causality. J Antimicrob Chemother 1998; 42:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/92\">",
"      Asensio A, Guerrero A, Quereda C, et al. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996; 17:20.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/93\">",
"      Schneider-Lindner V, Delaney JA, Dial S, et al. Antimicrobial drugs and community-acquired methicillin-resistant Staphylococcus aureus, United Kingdom. Emerg Infect Dis 2007; 13:994.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/94\">",
"      Hidron AI, Kourbatova EV, Halvosa JS, et al. Risk factors for colonization with methicillin-resistant Staphylococcus aureus (MRSA) in patients admitted to an urban hospital: emergence of community-associated MRSA nasal carriage. Clin Infect Dis 2005; 41:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/95\">",
"      Mathews WC, Caperna JC, Barber RE, et al. Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults. J Acquir Immune Defic Syndr 2005; 40:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/96\">",
"      Szumowski JD, Wener KM, Gold HS, et al. Methicillin-resistant Staphylococcus aureus colonization, behavioral risk factors, and skin and soft-tissue infection at an ambulatory clinic serving a large population of HIV-infected men who have sex with men. Clin Infect Dis 2009; 49:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/97\">",
"      Popovich KJ, Smith KY, Khawcharoenporn T, et al. Community-associated methicillin-resistant Staphylococcus aureus colonization in high-risk groups of HIV-infected patients. Clin Infect Dis 2012; 54:1296.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/98\">",
"      Centers for Disease Control and Prevention (CDC). Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients--United States, 2005. MMWR Morb Mortal Wkly Rep 2007; 56:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/99\">",
"      Spindel SJ, Strausbaugh LJ, Jacobson C. Infections caused by Staphylococcus aureus in a Veterans' Affairs nursing home care unit: a 5-year experience. Infect Control Hosp Epidemiol 1995; 16:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/100\">",
"      Lubin AS, Snydman DR, Ruthazer R, et al. Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infections. Clin Infect Dis 2011; 52:997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/101\">",
"      Chen SY, Liao CH, Wang JL, et al. Methicillin-resistant Staphylococcus aureus (MRSA) staphylococcal cassette chromosome mec genotype effects outcomes of patients with healthcare-associated MRSA bacteremia independently of vancomycin minimum inhibitory concentration. Clin Infect Dis 2012; 55:1329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/102\">",
"      Lucet JC, Paoletti X, Demontpion C, et al. Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch Intern Med 2009; 169:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/103\">",
"      Kuehnert MJ, Kruszon-Moran D, Hill HA, et al. Prevalence of Staphylococcus aureus nasal colonization in the United States, 2001-2002. J Infect Dis 2006; 193:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/104\">",
"      Kenner J, O'Connor T, Piantanida N, et al. Rates of carriage of methicillin-resistant and methicillin-susceptible Staphylococcus aureus in an outpatient population. Infect Control Hosp Epidemiol 2003; 24:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/105\">",
"      Reboli AC, John JF Jr, Platt CG, Cantey JR. Methicillin-resistant Staphylococcus aureus outbreak at a Veterans' Affairs Medical Center: importance of carriage of the organism by hospital personnel. Infect Control Hosp Epidemiol 1990; 11:291.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/106\">",
"      Coello R, Jim&eacute;nez J, Garc&iacute;a M, et al. Prospective study of infection, colonization and carriage of methicillin-resistant Staphylococcus aureus in an outbreak affecting 990 patients. Eur J Clin Microbiol Infect Dis 1994; 13:74.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/107\">",
"      Sanford MD, Widmer AF, Bale MJ, et al. Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 1994; 19:1123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/108\">",
"      Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/109\">",
"      Boyce JM, Havill NL, Maria B. Frequency and possible infection control implications of gastrointestinal colonization with methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43:5992.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/110\">",
"      Boyce JM, Opal SM, Potter-Bynoe G, Medeiros AA. Spread of methicillin-resistant Staphylococcus aureus in a hospital after exposure to a health care worker with chronic sinusitis. Clin Infect Dis 1993; 17:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/111\">",
"      Sherertz RJ, Reagan DR, Hampton KD, et al. A cloud adult: the Staphylococcus aureus-virus interaction revisited. Ann Intern Med 1996; 124:539.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/112\">",
"      Cook HA, Furuya EY, Larson E, et al. Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2007; 44:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/113\">",
"      Chen KT, Huard RC, Della-Latta P, Saiman L. Prevalence of methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant women. Obstet Gynecol 2006; 108:482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/114\">",
"      Rohr U, Wilhelm M, Muhr G, Gatermann S. Qualitative and (semi)quantitative characterization of nasal and skin methicillin-resistant Staphylococcus aureus carriage of hospitalized patients. Int J Hyg Environ Health 2004; 207:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/115\">",
"      Bhalla A, Aron DC, Donskey CJ. Staphylococcus aureus intestinal colonization is associated with increased frequency of S. aureus on skin of hospitalized patients. BMC Infect Dis 2007; 7:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/116\">",
"      Cookson B, Peters B, Webster M, et al. Staff carriage of epidemic methicillin-resistant Staphylococcus aureus. J Clin Microbiol 1989; 27:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/117\">",
"      Scanvic A, Denic L, Gaillon S, et al. Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage. Clin Infect Dis 2001; 32:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/118\">",
"      Ellis MW, Hospenthal DR, Dooley DP, et al. Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 2004; 39:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/119\">",
"      Robicsek A, Beaumont JL, Peterson LR. Duration of colonization with methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2009; 48:910.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/120\">",
"      Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997; 18:622.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/121\">",
"      Smith MA, Mathewson JJ, Ulert IA, et al. Contaminated stethoscopes revisited. Arch Intern Med 1996; 156:82.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/122\">",
"      Guinto CH, Bottone EJ, Raffalli JT, et al. Evaluation of dedicated stethoscopes as a potential source of nosocomial pathogens. Am J Infect Control 2002; 30:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?7/53/8026/abstract/123\">",
"      Boyce JM, Havill NL, Otter JA, Adams NM. Widespread environmental contamination associated with patients with diarrhea and methicillin-resistant Staphylococcus aureus colonization of the gastrointestinal tract. Infect Control Hosp Epidemiol 2007; 28:1142.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3157 Version 18.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-197.136.42.3-293D88DB16-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8026=[""].join("\n");
var outline_f7_53_8026=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Healthcare-associated methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Community-associated methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Evolving epidemiologic observations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Linezolid resistance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Colonization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14500218\">",
"      Methicillin-resistant Staphylococcus aureus infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Antibiotic use",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - HIV infection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Hemodialysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Long-term care facilities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14500258\">",
"      Methicillin-resistant Staphylococcus aureus infection with high vancomycin MIC",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      TRANSMISSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Colonization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Contaminated environmental surfaces",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/3157\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/3157|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?5/9/5275\" title=\"table 1\">",
"      Risk factors for MRSA",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/49/31514?source=related_link\">",
"      Epidemiology, pathogenesis, and microbiology of community-acquired pneumonia in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19658?source=related_link\">",
"      General principles of infection control",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/13/15575?source=related_link\">",
"      Microbiology of methicillin-resistant Staphylococcus aureus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/4/22595?source=related_link\">",
"      Patient information: Methicillin-resistant Staphylococcus aureus (MRSA) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/59/17338?source=related_link\">",
"      Prevention and control of methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/48/21258?source=related_link\">",
"      Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/7/4216?source=related_link\">",
"      Treatment of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/2/16425?source=related_link\">",
"      Vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f7_53_8027="Typical local reactions to mosquito bites";
var content_f7_53_8027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F63430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F63430&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Typical (normal) reactions to mosquito bites: Stages of development",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Stage",
"       </td>",
"       <td class=\"subtitle1\">",
"        Clinical findings",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        I",
"       </td>",
"       <td>",
"        No observable skin reaction (sensitization stage)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        II",
"       </td>",
"       <td>",
"        Delayed skin reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        III",
"       </td>",
"       <td>",
"        Immediate skin reaction followed by delayed skin reaction",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        IV",
"       </td>",
"       <td>",
"        Immediate skin reaction only",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\">",
"        V",
"       </td>",
"       <td>",
"        No reactivity (natural desensitization stage)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8027=[""].join("\n");
var outline_f7_53_8027=null;
var title_f7_53_8028="AAST kidney injury scale";
var content_f7_53_8028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F80576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F80576&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    American Association for the Surgery of Trauma organ injury severity scale for the kidney",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Grade",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Description",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"centered\" rowspan=\"2\">",
"        I",
"       </td>",
"       <td>",
"        Contusion",
"       </td>",
"       <td>",
"        Microscopic or gross hematuria, urologic studies normal",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hematoma",
"       </td>",
"       <td>",
"        Subcapsular, nonexpanding hematoma without parenchymal laceration",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"centered\" rowspan=\"2\">",
"        II",
"       </td>",
"       <td>",
"        Hematoma",
"       </td>",
"       <td>",
"        Nonexpanding perirenal hematoma confined to renal retroperitoneum",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Laceration",
"       </td>",
"       <td>",
"        Laceration &lt;1 cm depth of renal cortex without urinary extravasation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"centered\">",
"        III",
"       </td>",
"       <td>",
"        Laceration",
"       </td>",
"       <td>",
"        Laceration &gt;1 cm depth of renal cortex without collecting system rupture or urinary extravasation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"centered\" rowspan=\"2\">",
"        IV",
"       </td>",
"       <td>",
"        Laceration",
"       </td>",
"       <td>",
"        Parenchymal laceration extending through renal cortex, medulla, and collecting system",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular",
"       </td>",
"       <td>",
"        Main renal artery or vein injury with contained hemorrhage",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"centered\" rowspan=\"2\">",
"        V",
"       </td>",
"       <td>",
"        Laceration",
"       </td>",
"       <td>",
"        Completely shattered kidney",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Vascular",
"       </td>",
"       <td>",
"        Avulsion of renal hilum, devascularizing the kidney",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Santucci RA, McAninch JW, Safir M, et al. Validation of the American Association for the Surgery of Trauma organ injury severity scale for the kidney. J Trauma 2001; 50:195. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8028=[""].join("\n");
var outline_f7_53_8028=null;
var title_f7_53_8029="SCIT practice parameter";
var content_f7_53_8029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F75703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F75703&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Summary statements from allergen immunotherapy practice parameters (3rd update) addressing prevention of severe systemic reactions to subcutaneous immunotherapy (SCIT)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Uncontrolled asthma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Risk factors for severe immunotherapy reactions include symptomatic asthma and injections administered during periods of symptom exacerbation. Before the administration of the allergy injection, the patient should be evaluated for the presence of asthma or allergy symptom exacerbation. One might also consider an objective measure of airway function (eg, peak flow) for the asthmatic patient before allergy injections.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Medical conditions that reduce the patient's ability to survive the systemic allergic reaction or the resultant treatment are relative contraindications for allergen immunotherapy. Examples include severe asthma uncontrolled by pharmacotherapy and significant cardiovascular disease.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergen immunotherapy in asthmatic patients should not be initiated unless the patient's asthma is stable with pharmacotherapy.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Optimizing safety in the clinic setting",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Because most systemic reactions that result from allergen immunotherapy occur within 30 minutes after an injection, patients should remain in the clinician's office at least 30 minutes after an injection. Some patients may need to wait longer, such as patients with prior systemic reactions that occurred later than 30 minutes after an injection.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Allergen immunotherapy should be administered in a setting where procedures that can reduce the risk of anaphylaxis are in place and where the prompt recognition and treatment of anaphylaxis is ensured.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Concomitant administration of beta blockers and ACE inhibitors",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Beta-adrenergic blocking agents might make allergen immunotherapy-related systemic reactions more difficult to treat and delay the recovery. Therefore a cautious attitude should be adopted toward the concomitant use of beta-blocker agents and inhalant allergen immunotherapy. However, immunotherapy is indicated in patients with life-threatening stinging insect hypersensitivity who also require beta-blocker medications because the risk of the stinging insect hypersensitivity is greater than the risk of an immunotherapy-related systemic reaction.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        ACE inhibitors have been associated with a greater risk for more severe systemic&nbsp;reactions from venom immunotherapy, as well as from field stings. ACE inhibitor discontinuation should be considered for patients receiving venom immunotherapy.&nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Local reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Published studies indicate that individual local reactions do not appear to be predictive of subsequent systemic reactions. However, some patients with greater frequency of large local reactions might be at an increased risk for future systemic reactions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Dose adjustments and administration in patients with prior systemic reactions",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The dose of allergen immunotherapy extract should be appropriately reduced after a systemic reaction if immunotherapy is continued.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Patients at high risk of systemic reactions, where possible, should receive immunotherapy in the office of the&nbsp;clinician who prepared the patient's allergen immunotherapy extract.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Adminstration of SCIT during periods of high allergen exposure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Immunotherapy given during periods when the patient is exposed to increased levels of allergen to which they are sensitive might be associated with an increased risk of a systemic reaction. Consider not increasing or even reducing the immunotherapy dose in highly sensitive patients during the time period when they are exposed to increased levels of allergen, especially if they are experiencing an exacerbation of their symptoms.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Source: Cox L, Nelson H, Lockey R. Allergen immunotherapy: a practice parameter&nbsp;third update. J Allergy Clin Immunol 2011; 127(1 Suppl):S1.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8029=[""].join("\n");
var outline_f7_53_8029=null;
var title_f7_53_8030="Management of SVCS in children with a mediastinal mass";
var content_f7_53_8030=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F78852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F78852&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Management of mediastinal mass in children",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 350px; height: 580px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Assessment and management of a child with superior vena cava or superior mediastinal syndrome due to a mediastinal mass who presents with respiratory distress, cough, and/or pleural effusions.",
"    <div class=\"footnotes\">",
"     SVCS/SMS: superior vena cava syndrome/superior mediastinal syndrome; CXR: chest radiograph; CBC: complete blood count.",
"     <br>",
"      * The risk assessment for anestheta includes computed tomography of the chest, echocardiography, pulmonary function studies, and flow volume loop. If the patient cannot tolerate these studies, or if the studies indicate severely compromised cardiopulmonary reserve, the patient is a high anesthetic risk.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Rheingold SR, Lange BJ. Oncologic Emergencies. In: Principles and Practice of Pediatric Oncology, 5th ed, Pizzo PA, Poplack DG (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. Copyright &copy; 2006 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8030=[""].join("\n");
var outline_f7_53_8030=null;
var title_f7_53_8031="Congenital cholesteatoma in the superior posterior quadrant";
var content_f7_53_8031=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F70826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F70826&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Congenital cholesteatoma in the superior posterior quadrant",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 375px; height: 372px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f7_53_8031=[""].join("\n");
var outline_f7_53_8031=null;
